Price
1,000
+0.21%52W Range
Market Cap
₹97,324.38 Cr
Traded: ₹123.09 Cr (0.13%) 0.0x
Free Float: ₹4,428.26 Cr (2.78% of FF traded)
Volume · 60D trend
12.37 L 0.0x
Delivery: % 0.0x
View Delivery Data
Returns
Valuation
Business Strength
Growth (3Y CAGR)
Balance Sheet
Cash Position
Others
MTF Exposure Trend
60 sessions · funded amount, % of FF, daily delta
LAX.SH
Growth Trends
| Metric | 10Y | 5Y | 3Y | 1Y | TTM | Trend |
|---|---|---|---|---|---|---|
| Sales | -- | +27.0% | +22.0% | -- | +16.0% | Decelerating |
| ROE | +11.0% | +14.0% | +14.0% | -- | -- | Stable |
| Return | -- | +26.0% | +25.0% | -20.0% | -- | Decelerating |
| Profit | -- | +60.0% | +10.0% | -- | +25.0% | Stable |
Quarterly Results
Mar 2023
Dec 2022
Sep 2022
Revenue & Margin Trends
Annual
Quarterly
Balance Sheet Health
Leverage
Efficiency
Cash Position
Detailed Financials
Jun 2026PDF ↗ | Mar 2026PDF ↗ | Dec 2025PDF ↗ | Sep 2025PDF ↗ | Jun 2025PDF ↗ | Mar 2025PDF ↗ | Dec 2024PDF ↗ | Sep 2024PDF ↗ | Jun 2024PDF ↗ | Mar 2024PDF ↗ | Dec 2023PDF ↗ | Sep 2023PDF ↗ | Jun 2023PDF ↗ | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,366 | 2,143 | 2,068 | 2,135 | 2,028 | 1,910 | 1,868 | 1,707 | 1,543 | 1,423 | 1,335 | 1,363 | 1,285 | 1,215 | 1,142 | 1,137 |
| Expenses | 1,768 | 1,536 | 1,529 | 1,560 | 1,505 | 1,398 | 1,369 | 1,257 | 1,156 | 1,041 | 949 | 976 | 948 | 874 | 828 | 818 |
| Operating Profit | 598 | 606 | 538 | 575 | 523 | 512 | 499 | 451 | 387 | 382 | 386 | 387 | 337 | 340 | 314 | 319 |
| OPM % | 25.0% | 28.0% | 26.0% | 27.0% | 26.0% | 27.0% | 27.0% | 26.0% | 25.0% | 27.0% | 29.0% | 28.0% | 26.0% | 28.0% | 28.0% | 28.0% |
| Other Income | 41 | 48 | -3 | 33 | 37 | 47 | -40 | 41 | 35 | 45 | 46 | 45 | 41 | 40 | 45 | 26 |
| Interest | 71 | 67 | 60 | 54 | 55 | 55 | 52 | 34 | 24 | 21 | 11 | 9 | 19 | 20 | 20 | 22 |
| Depreciation | 132 | 123 | 111 | 108 | 104 | 101 | 98 | 84 | 77 | 70 | 61 | 58 | 56 | 60 | 57 | 58 |
| Profit Before Tax | 436 | 465 | 365 | 446 | 400 | 402 | 309 | 374 | 321 | 336 | 360 | 366 | 303 | 301 | 281 | 265 |
| Tax % | 26.0% | 26.0% | 17.0% | -10.0% | 23.0% | 21.0% | 23.0% | 25.0% | 26.0% | 25.0% | 20.0% | 24.0% | 21.0% | 17.0% | 21.0% | -72.0% |
| Net Profit | 323 | 342 | 301 | 491 | 308 | 319 | 239 | 282 | 236 | 252 | 289 | 277 | 240 | 251 | 222 | 457 |
| Exceptional Items | -- | 0 | -48 | 0 | 0 | 0 | -74 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Rs) | 3.3 | 3.5 | 3.1 | 5.0 | 3.2 | 3.3 | 2.5 | 2.9 | 2.4 | 2.6 | 3.0 | 2.9 | 2.5 | 2.6 | 2.3 | 4.7 |
| Sales Growth (YoY) | 16.7% | 12.2% | 10.7% | 25.1% | 31.4% | 34.2% | 39.9% | 25.2% | 20.1% | 17.1% | 16.9% | 19.9% | -- | -- | -- | -- |
| Sales Growth (QoQ) | 10.4% | 3.6% | -3.1% | 5.3% | 6.2% | 2.3% | 9.4% | 10.6% | 8.4% | 6.6% | -2.0% | 6.1% | 5.8% | 6.4% | 0.4% | -- |
| OP Growth (YoY) | 14.3% | 18.4% | 7.8% | 27.5% | 35.1% | 34.0% | 29.3% | 16.5% | 14.8% | 12.4% | 22.9% | 21.3% | -- | -- | -- | -- |
| OP Growth (QoQ) | -1.3% | 12.6% | -6.4% | 9.9% | 2.1% | 2.6% | 10.6% | 16.5% | 1.3% | -1.0% | -0.3% | 14.8% | -0.9% | 8.3% | -1.6% | -- |
| Profit Growth (YoY) | -- | 7.0% | 17.0% | 74.0% | 30.0% | 27.0% | 0.0% | 2.0% | -2.0% | 0.0% | 30.0% | -40.0% | 39.0% | 103.0% | 17.0% | 203.0% |
| EPS Growth (YoY) | 4.7% | 7.3% | 25.6% | 74.1% | 30.4% | 26.6% | -17.4% | 1.8% | -1.6% | 0.4% | 30.1% | -39.6% | -- | -- | -- | -- |
| EPS Growth (QoQ) | -5.7% | 13.9% | -38.8% | 59.3% | -3.4% | 33.3% | -15.2% | 19.3% | -6.2% | -13.1% | 4.6% | 15.4% | -4.3% | 12.7% | -51.5% | -- |
| OP Margin | 25.3% | 28.3% | 26.0% | 26.9% | 25.8% | 26.8% | 26.7% | 26.4% | 25.1% | 26.8% | 28.9% | 28.4% | 26.2% | 28.0% | 27.5% | 28.1% |
| Net Margin | 13.7% | 16.0% | 14.6% | 23.0% | 15.2% | 16.7% | 12.8% | 16.5% | 15.3% | 17.7% | 21.6% | 20.3% | 18.7% | 20.7% | 19.4% | 40.2% |
| Material Cost % | 21.7% | 20.5% | 21.3% | 21.8% | 22.0% | 21.4% | 21.0% | 20.4% | 21.2% | 20.8% | 20.0% | 20.5% | 21.5% | 20.3% | 20.1% | 19.9% |
| Employee Cost % | 16.4% | 15.9% | 16.5% | 15.8% | 16.7% | 16.5% | 16.3% | 16.6% | 17.5% | 17.0% | 17.3% | 17.3% | 17.6% | 17.3% | 17.9% | 17.3% |
| P/S | 11.17 | 11.71 | 13.04 | 13.38 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/E | 66.76 | 67.94 | 74.78 | 78.22 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| P/B | 9.06 | 9.12 | 10.56 | 10.57 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- |
Exchange Filings
50Transcript of Earnings Call held on August 14, 2026
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Presentation for Investor Conference
Newspaper Publication pertaining to Financial Results for the quarter ended June 30, 2026
Audio Recording of Earnings Call held on August 14, 2026
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Presentation on earnings updates for the quarter ended June 30, 2026
Change in Senior Management Personnel
Press Release - Max Healthcare Q1 revenue rises to Rs. 2,982 Cr, registering growth of 16% YoY; Network Operating EBITDA rises to Rs. 704 Cr, 15% YoY; Q1 PAT was Rs. 357 Cr
Results - Financial Results for the quarter ended June 30, 2026
Outcome of Board Meeting held on August 13, 2026
Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Grant of options under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Schedule of Investor Conference
Schedule of Earnings Call for Investors and Analysts
Max Healthcare Institute Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve unaudited standalone ....
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Minutes of 25th Annual General Meeting
Summary of Proceedings of 25th Annual General Meeting
Voting Results and Scrutinizer''s Report for 25th Annual General Meeting
Voting Results and Scrutinizer''s Report for 25th Annual General Meeting
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Schedule of Investor Conference/ Meet
Newspaper Publication - Notice of 25th Annual General Meeting and E-Voting Information
Business Responsibility and Sustainability Report for the financial year 2025-26
Notice of 25th Annual General Meeting and Integrated Annual Report for the financial year 2025-26
Notice of 25th Annual General Meeting and Integrated Annual Report for the financial year 2025-26
Disclosure under regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Allotment of Equity Shares under Max Healthcare Institute Limited - Employee Stock Option Scheme 2022
Communication to members - Second 100-Days Campaign - Saksham Niveshak
Receipt of No-objection letters for re-classification of Radiant Life Care Hospital Foundation from Promoter Group to Public category
Update on Share Purchase Agreement to acquire equity stake in Yerawada Properties Private Limited and matters relating to setting up a ~450 bedded super speciality hospital in Pune
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Newspaper Publication - Information regarding 25th Annual General Meeting, Dividend and Record Date
Closure of Trading Window
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Intimation of Annual General Meeting, Record Date and Communication to member for deduction of tax at source on final dividend
Intimation of Annual General Meeting, Record Date and Communication to members for deduction of tax at source on final dividend
Schedule of Investor Conference
Schedule of Investor Conference
Transcript of Earnings Call held on May 22, 2026
Schedule of Investor Conference
Presentation for Investor Conference
Update on re-classification of Radiant Life Care Hospital Foundation (formerly known as Radiant Life Care Foundation) from Promoter Group to Public category
Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Schedule of Investor Conference
Audio Recording of Earnings Call held on May 22, 2026
Newspaper publication pertaining to Financial Results for the quarter and financial year ended March 31, 2026
Presentation on earnings update for the fourth quarter and financial year ended March 31, 2026
Annual Reports
7Credit Ratings
6Concalls
43Feb 2026
28 Feb 2026Feb 2026
28 Feb 2026Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Nov 2025
30 Nov 2025Aug 2025
31 Aug 2025Aug 2025
31 Aug 2025May 2025
31 May 2025May 2025
31 May 2025Feb 2025
28 Feb 2025Jan 2025
31 Jan 2025Nov 2024
30 Nov 2024Nov 2024
30 Nov 2024Aug 2024
31 Aug 2024Aug 2024
31 Aug 2024May 2024
31 May 2024May 2024
31 May 2024May 2024
31 May 2024Feb 2024
29 Feb 2024Jan 2024
31 Jan 2024Nov 2023
30 Nov 2023Nov 2023
30 Nov 2023Aug 2023
31 Aug 2023Aug 2023
31 Aug 2023May 2023
31 May 2023Feb 2023
28 Feb 2023Feb 2023
28 Feb 2023Nov 2022
30 Nov 2022Nov 2022
30 Nov 2022Aug 2022
31 Aug 2022Jun 2022
30 Jun 2022Feb 2022
28 Feb 2022Nov 2021
30 Nov 2021May 2021
31 May 2021Mar 2021
31 Mar 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Feb 2021
28 Feb 2021Nov 2020
30 Nov 2020Sep 2020
30 Sept 2020Aug 2020
31 Aug 2020Held by ETFs
62 ETFs hold maxhealth · sorted by weight
Held by Mutual Funds
187 schemes hold maxhealth · sorted by weight